Author:
Bing Zhu,Jianru Yang,Yuequan Jiang,Shifeng Chen,Xinping Fu
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference10 articles.
1. McNeish, I. A., Bell, S. J., & Lemoine, N. R. (2004). Gene therapy progress and prospects: Cancer gene therapy using tumor suppressor genes. Gene Therapy, 11, 497–503.
2. Faifh, S. A., Sweet, T. J., Bailey, E., et al. (2006). Resveratrol suppresses nuclear factor-kappa B in herpes simplex virus infected cells. Antiviral Research, 72, 242–251.
3. Fu, X. P., Feng, M., Tao, L. H., et al. (2003). A strict late viral promoter is a strong tumor-specific promoter in the context of an oncolytic herpes simplex virus. Gene Therapy, 10, 1458–1466.
4. Higuchi, H., Bronk, S. F., Bateman, A., et al. (2000). Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: Implications for gene therapy. Cancer Research, 60, 6396–6402.
5. Spector, D. L., Goldman, R. D., & Leinwand, L. A. (2001). Cells: A laboratory manual (pp. 830–831). Beijing: Science Press. Translated by Huang PT.